Back to the main directory
Press Release
- Nxu Repays Nearly $20 Million of Convertible Notes by GlobeNewsWire
- Hut 8 Mining Production and Operations Update for October 2023 by GlobeNewsWire
- BioNTech veröffentlicht Ergebnisse des dritten Quartals 2023 und Informationen zur Geschäftsentwicklung by GlobeNewsWire
- Hut 8 Provides Update on Business Combination with USBTC by GlobeNewsWire
- Brookfield Asset Management Announces Strong Third Quarter Results by GlobeNewsWire
- Asensus Surgical Announces Klinikum Idar-Oberstein Hospital in Germany to Initiate Senhance Surgery Program by GlobeNewsWire
- ADC Therapeutics nimmt an der Jefferies London Healthcare Conference teil by GlobeNewsWire
- ProQR Strengthens Leading Intellectual Property Estate for ADAR-mediated RNA Editing by GlobeNewsWire
- REMINDER: Stella-Jones Will Hold a Conference Call to Discuss Its Third-Quarter Results by GlobeNewsWire
- Stran & Company Announces 42% Increase in Revenue and Reports Profitable Net Earnings for the Third Quarter of 2023 by GlobeNewsWire
- Akoustis to Webcast Q1FY24 Results on November 13 at 8:00 am ET by GlobeNewsWire
- ACELYRIN, INC. Appoints Patricia Turney as Chief Technical Operations Officer by GlobeNewsWire
- Marimaca Announces Results from Phase 6 Metallurgical Program by GlobeNewsWire
- Aclaris Therapeutics Reports Third Quarter 2023 Financial Results and Provides a Corporate Update by GlobeNewsWire
- Lithium Ionic drills 1.64% Li2O over 13.5m, 2.18% Li2O over 5.8m and 1.95% Li2O over 5.7m at Bandeira, Minas Gerais, Brazil by GlobeNewsWire
- TScan Therapeutics Presents Phase 1 Trial Design for Solid Tumor Program at the Society for Immunotherapy of Cancer 38th Annual Meeting by GlobeNewsWire
- Telesat Reports Results for the Quarter and Nine Months Ended September 30, 2023 by GlobeNewsWire
- Medicenna Announces Promising Single-Agent Response and Durability of MDNA11 in the Phase 1/2 ABILITY Study During Dose Escalation at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) by GlobeNewsWire
- Darren Entwistle, président et chef de la direction de TELUS, témoigne de sa grande confiance dans l’avenir de l’entreprise en achetant des actions by GlobeNewsWire
- Ginkgo Bioworks and XWELL Implement Expanded CDC Traveler-based Genomic Surveillance Program to Test for More than 30 Known Pathogens by GlobeNewsWire
- Kaixin Auto Holdings Announces Resignation of Director by GlobeNewsWire
- Autolus Therapeutics announces participation in upcoming conferences by GlobeNewsWire
- ZyVersa Therapeutics Announces Article in Peer-Reviewed Journal, Ecotoxicology and Environmental Safety, Linking Air Pollution with Development and Progression of Chronic Kidney Disease That Can Be Attenuated by Inhibiting Inflammasome NLRP3 Activation by GlobeNewsWire
- Virios Therapeutics to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023 by GlobeNewsWire
- Hardman & Co Q&A on ICG Enterprise Trust (ICGT): 1H FY’24: defensive growth paying off by EQS Group AG